BC-LI-0186 [695207-56-8]

TargetMol Chemicals

BC-LI-0186 [695207-56-8]

4

695207-56-8

Chemical

Research Use Only

BC-LI-0186

99.17%

C22H27N3O4S

429.53

BC-LI-0186 (4-(2,3-dimethyl-5-oxo-4-propan-2-ylpyrazol-1-yl)-N-(2-phenoxyethyl)benzenesulfonamide) is a potent and selective inhibitor of the interaction of Leucyl-tRNA synthetase (LRS) and Ras-related GTP-binding protein D (RagD) with IC50 of 46.11 nM. BC-LI-0186 competitively binds the RagD interaction site of LRS with Kd of 42.1 nM and has no effect on LRS-vps34, LRS-eprs, RagB-RagD association, mTORC1 complex formation. BC-LI-0186 potently inhibits the activity of tumor-associated MTOR mutants and the growth of rapamycin-resistant cancer cells. BC-LI-0186 can be used for lung cancer-related research.

3 years

CC(C)c1c(C)n(C)n(-c2ccc(cc2)S(=O)(=O)NCCOc2ccccc2)c1=O

-20°C

12352200